![Daniella Beckman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Daniella Beckman
Director/Board Member at
VOR BIOPHARMA INC.
Net worth: 4 M $ as of 30/06/2026
Profile
Daniella Beckman is Lead Independent Director at Vor Biopharma, Inc. since 2026 and Independent Director at Upstream Bio, Inc. since 2024.
Former roles include Independent Director at Blueprint Medicines Corp.
from 2021 to 2025, Independent Director at 5:01 Acquisition Corp.
from 2020 to 2022, Independent Director at Translate Bio, Inc. from 2017 to 2021, Chief Financial Officer & PAO at Tango Therapeutics, Inc. from 2016 to 2026, Chief Financial Officer at BioNTech US, Inc. from 2015 to 2019, Chief Financial Officer at Beckman Consulting LLC from 2015 to 2019, CFO, Treasurer, Director & Vice President at Idenix Pharmaceuticals LLC from 2011 to 2014.
Education includes undergraduate studies at Boston University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 01/04/2026 | 131,689 ( 0.12% ) | 4 M $ | 30/06/2026 | |
UPSTREAM BIO, INC. -.--% | 09/06/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
VOR BIOPHARMA, INC. -.--% | 11/06/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
Daniella Beckman active positions
| Companies | Position | Start |
|---|---|---|
| VOR BIOPHARMA INC. | Director/Board Member | 16/07/2020 |
| UPSTREAM BIO, INC. | Director/Board Member | 11/10/2024 |
Former positions of Daniella Beckman
| Companies | Position | End |
|---|---|---|
| TANGO THERAPEUTICS, INC. | Director of Finance/CFO | 15/04/2026 |
| BLUEPRINT MEDICINES CORPORATION | Director/Board Member | 17/07/2025 |
| 501 ACQU | Director/Board Member | 01/01/2022 |
| TRANSLATE BIO, INC. | Director/Board Member | 14/09/2021 |
| NEON THERAPEUTICS, INC. | Director of Finance/CFO | 01/09/2019 |
Training of Daniella Beckman
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
58
1st degree connections
10
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Idenix Pharmaceuticals LLC
 Idenix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for the treatment of human viral and infectious diseases caused by hepatitis | Health Technology |
Translate Bio, Inc.
 Translate Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage mRNA therapeutics company that develops transformative medicines to treat diseases caused by protein | Health Technology |
Boston University
 Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Blueprint Medicines Corp.
 Blueprint Medicines Corp. BiotechnologyHealth Technology Develops cancer therapies that harness the growing understanding of the molecular blueprint of cancer | Health Technology |
BioNTech US, Inc.
 BioNTech US, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops immunotherapies for cancer | Health Technology |
Vor Biopharma, Inc.
 Vor Biopharma, Inc. BiotechnologyHealth Technology Engages in developing cell therapies | Health Technology |
5:01 Acquisition Corp.
 5:01 Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Beckman Consulting LLC
 Beckman Consulting LLC Miscellaneous Commercial ServicesCommercial Services Engages in the provision of consulting services | Commercial Services |
Tango Therapeutics, Inc.
 Tango Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company that engages in discovering and delivering precision cancer medicines | Health Technology |
Upstream Bio, Inc.
 Upstream Bio, Inc. BiotechnologyHealth Technology Engages in developing treatments for inflammatory diseases | Health Technology |
- Stock Market
- Insiders
- Daniella Beckman
